Astex Pharmacaeuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Astex Pharmacaeuticals's estimated annual revenue is currently $75M per year.(i)
  • Astex Pharmacaeuticals's estimated revenue per employee is $675,676

Employee Data

  • Astex Pharmacaeuticals has 111 Employees.(i)
  • Astex Pharmacaeuticals grew their employee count by -33% last year.

Astex Pharmacaeuticals's People

NameTitleEmail/Phone
1
CPA, VP, FinanceReveal Email/Phone
2
CSOReveal Email/Phone
3
SVP Medicinal ChemistryReveal Email/Phone
4
VP, Quality Assurance & ComplianceReveal Email/Phone
5
SVP, Corporate Development; Head Business DevelopmentReveal Email/Phone
6
VP Finance & AdminReveal Email/Phone
7
Head Human ResourcesReveal Email/Phone
8
SVP InformaticsReveal Email/Phone
9
SVP, Head ChemistryReveal Email/Phone
10
VP ChemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Astex Pharmacaeuticals?

Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the development and commercialization of products intended to treat life-threatening diseases, particularly cancer.

keywords:N/A

N/A

Total Funding

111

Number of Employees

$75M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Astex Pharmacaeuticals News

2022-04-17 - Fragment-Based Drug Discovery Market Research Report 2022 ...

Fragment-Based Drug Discovery Market Research Report 2022| Astex Pharmaceuticals, Alveus Pharmaceuticals Pvt. Ltd, Beactica AB.

2022-04-13 - Introducing Clinical Trial Updates | Journal of Clinical Oncology

Research Funding: Taiho Pharmaceutical (Inst), Novartis (Inst), Seattle Genetics (Inst), Pfizer (Inst), Astex Pharmaceuticals (Inst),...

2022-03-30 - Race Oncology inks supply agreement with Astex Pharmaceuticals to supply ASTX727 for cancer drug Zantrene"s trials

Race Oncology inks supply agreement with Astex Pharmaceuticals to supply ASTX727 for cancer drug Zantrene's trials.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20M1118%N/A
#2
$28.4M11213%N/A
#3
$11.3M113-3%N/A
#4
$300M113-6%$77.9M
#5
$18.1M113102%N/A